Slide Presentation from the AHRQ 2007 Annual Conference

Automated ADE Surveillance: Challenges

• Looking where the light is: we are limited by available data types
  • Performs consistently across large populations, but is not comprehensive
• Resource requirement for evaluations
• How best to use the data on ADE incidence
  • Used as a primary measure of medication safety?
  • Is it used to design, implement, monitor safety improvements?